UNSPSC 51123902: Eproxindine

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E229K2HE7F. European Medicines Agency schedules Eproxindine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06588MIG. Eproxindine generally arises in the molecular formula C23H29N3O3.

UNSPSC 51123902 Eproxindine is a Commodity code representing pharmaceutical products acquired by state and local emergency services for advanced life support protocols. State and local governments procure these medications—including epinephrine, adenosine, labetalol, and diltiazem—for fire rescue departments, emergency medical services, and affiliated healthcare facilities. Issuing bodies acquiring under this code are primarily municipal fire departments and city purchasing offices acting on their behalf, supported by local emergency services operations. Procurement is typically structured as sealed competitive bid solicitations with firm pricing and supplier warranties covering defect-free material for a minimum of 365 days. State and local buyers enforce strict expiration-date requirements (commonly nine months or more from acceptance) and require suppliers to handle pickup and replacement of expired stock before contract end. Delivery windows are tight—often ten calendar days of order receipt or faster—and shipping costs, freight, and applicable taxes must be included in the firm bid price.

The City of Tampa's Purchasing Department posted a representative opportunity on April 24, 2026 (Solicitation 26P00188, due April 8, 2026) through the OpenGov eProcurement Portal, seeking Advanced Life Support Medications including 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, 370 units of Labetalol HCI 100mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue in Hillsborough County, Florida. The solicitation carried an estimated contract value of $40,000.00, a one-year initial term with two optional one-year renewals plus three unilateral 30-day extensions, and a Small Local Business Enterprise (SLBE) sheltered market designation offering a 5 percent bid discount capped at $10,000. The award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening. Vendors were required to submit Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation meeting WCAG 2.2 Level AA and Section 508 standards. Activity under this code appears limited to the recent Tampa opportunity; no other state or local solicitations for eproxindine or closely related advanced life support pharmaceuticals are present in the source.